Daiken Biomedical Co., Ltd. (TPE:7780)
22.25
+2.00 (9.88%)
At close: Apr 2, 2026
22.93% (1Y)
| Market Cap | 18.02B +73.6% |
| Revenue (ttm) | 1.90B +39.1% |
| Net Income | 337.87M +217.0% |
| EPS | 0.51 +111.0% |
| Shares Out | 810.02M |
| PE Ratio | 43.95 |
| Forward PE | 31.47 |
| Dividend | 0.70 (3.14%) |
| Ex-Dividend Date | Nov 24, 2025 |
| Volume | 7,407,595 |
| Average Volume | 4,284,886 |
| Open | 20.70 |
| Previous Close | 20.25 |
| Day's Range | 20.55 - 22.25 |
| 52-Week Range | 14.65 - 40.10 |
| Beta | n/a |
| RSI | 56.87 |
| Earnings Date | Apr 23, 2026 |